- NHS Trusts will be able to bid for funding to accelerate
the deployment of the most promising AI tools
across hospitals to help treat people more quickly this
winter
- Government commits to deploying AI decision support
tools in all stroke networks by the end of 2023 to
help treat strokes through improved diagnosis and
access to treatment
- Ring-fenced funding announced by the Health and Social Care
Secretary ahead of the NHS’s 75thbirthday
NHS staff will be given the latest artificial intelligence (AI)
technology to diagnose and treat patients more quickly thanks to
a new £21 million fund announced by the Health and Social Care
Secretary today.
NHS Trusts will be able to apply to the AI Diagnostic Fund
to accelerate the deployment of the most promising AI imaging and
decision support tools to help diagnose patients more quickly for
conditions such as cancers, strokes and heart conditions.
The Health and Social Care Secretary has also committed to
rolling out AI stroke-diagnosis technology to 100% of stroke
networks by the end of 2023 – up from 86% today – helping
thousands of patients suffering from a stroke get treated faster.
The ring-fenced funding was announced by Health and
Social Care Secretary, , ahead of the NHS’s
75th birthday.
Health and Social Care Secretary said:
“Artificial intelligence is already transforming the way we
deliver healthcare and AI tools are already making a significant
impact across the NHS in diagnosing conditions earlier, meaning
people can be treated more quickly.
“As we celebrate the NHS’s 75th birthday and look
ahead to the future, I’m focused on adopting the latest
cutting-edge technology across our health and care system to
ensure we can continue to deliver the best care for our patients
and cut waiting times, which is one of the government’s five
priorities.”
This AI Diagnostic Fund will include the use of AI tools to
analyse chest X-Rays - the most common tool used to diagnose lung
cancer - which is the leading cause of cancer death in the UK.
With over 600,000 chest X-rays performed each month in England,
the deployment of diagnostic AI tools to more NHS Trusts will
support clinicians to diagnose cancer patients earlier, improving
patient outcomes.
The use of AI in the NHS is already having a positive impact on
outcomes for patients, with AI in some cases halving the time for
stroke victims to get the treatment they need by helping doctors
diagnose stroke faster, which has been shown to triple the chance
of patients living independently after a stroke.
The £21 million funding will be open for bids for any AI
diagnostic tool that trusts want to deploy, but will have to
represent value for money for the funding to be approved.
The government has already invested £123 million into 86 AI
technologies, which is helping patients by supporting stroke
diagnosis, screening, cardiovascular monitoring and managing
conditions at home.
Dr Katharine Halliday, President of the Royal College of
Radiologists said:
“At a time when diagnostic services are under strain, it is
critical that we embrace innovation that could boost capacity –
and so we welcome the Government’s announcement of a £21 million
fund to purchase and deploy AI diagnostic tools.
“All doctors want to give patients the best possible care. This
starts with a timely diagnosis, and crucially, catching disease
at the earliest point. There is huge promise in AI, which could
save clinicians time by maximising our efficiency, supporting our
decision-making and helping identify and prioritise the most
urgent cases. Together with a highly trained and expert
radiologist workforce, AI will undoubtedly play a significant
part in the future of diagnostics.”
The government also recently announced a new AI & Digital
Regulation Service to help NHS staff find the right information
and guidance when it comes to deploying AI devices
safely. This has made it easier for developers and
adopters of AI to understand regulations governing AI in the NHS
and is saving them time in bringing products to market.
For medical technology alone, the NHS spends £10 billion a year
and the global market is forecast to reach £150 billion next
year. Access to new technologies means patients benefit
enormously, with breakthroughs enabling prevention of ill-health,
earlier diagnosis, more effective treatments, and faster
recovery.